The promise of 3,4-methylenedioxymethamphetamine (MDMA) in combination with prolonged exposure therapy for posttraumatic stress disorder

pepapertier 3link oklink-only

Open source

ID
19cd83ab1c7447c7
Source org
OpenAlex
Author
Barbara O. Rothbaum et al.
Published
2022-07-20
OA status
green
DOI
10.1038/s41386-022-01381-7
PMID
—
PMCID
—
Citations
7

Tags

Verification

Automated checks only — not clinical endorsement or advice.

Cite this entry

BibTeX

@article{allodium:19cd83ab1c7447c7,
  title = {The promise of 3,4-methylenedioxymethamphetamine (MDMA) in combination with prolonged exposure therapy for posttraumatic stress disorder},
  author = {Barbara O. Rothbaum and Jessica L. Maples‐Keller},
  year = {2022},
  journal = {OpenAlex},
  doi = {10.1038/s41386-022-01381-7},
  url = {https://doi.org/10.1038/s41386-022-01381-7}
}

RIS

TY  - JOUR
TI  - The promise of 3,4-methylenedioxymethamphetamine (MDMA) in combination with prolonged exposure therapy for posttraumatic stress disorder
AU  - Rothbaum, Barbara O.
AU  - Maples‐Keller, Jessica L.
PY  - 2022
PB  - OpenAlex
DO  - 10.1038/s41386-022-01381-7
UR  - https://doi.org/10.1038/s41386-022-01381-7
ER  -

APA

Rothbaum, B. O., & Maples‐Keller, J. L. (2022). The promise of 3,4-methylenedioxymethamphetamine (MDMA) in combination with prolonged exposure therapy for posttraumatic stress disorder. OpenAlex. https://doi.org/10.1038/s41386-022-01381-7

Related entries